Uncover featured projects and success stories from Facet Life Sciences, showcasing our expertise in regulatory solutions.
Understanding Type B FDA Meetings
A Type B meeting (also called a Milestone Meeting or [...]
Understanding FDA Type A Meetings: Purpose, Process, and Key Considerations
For life sciences companies navigating the FDA regulatory landscape, Type [...]
FDA Type D Meetings: A New Option for Targeted, Time-Sensitive Regulatory Guidance
Effective communication with FDA through various FDA meetings is essential [...]
Expanded Access & Compassionate Use: FDA Guidelines & Key Facts
By: Lisa VanLuvanee, Ph.D. Expanded access, also known as compassionate [...]
What are the Different FDA Meeting Types for Drugs and Biologics?
Communication with FDA when developing innovative pharmaceuticals and biologics is [...]
Navigating the FDA’s Draft Guidance on Developing Cellular and Gene Therapy (CGT) Products
By Dr. Jason Mercer, Ph. D., RAC, Strategic Regulatory Innovator [...]
Gene Therapies in the Spotlight – A Major Trend in 2024
Cellular and gene therapies are one of the hottest product [...]
ICYMI – Q2 2024 – SNMMI’s Mars Shot
Facet Donates to SNMMI’s Mars Shot Facet is proud [...]
ICYMI – Q2 2024 – SNMMI
Facet Attends SNMMI In June, Dr. Lisa Jenkins VanLuvanee [...]
ICYMI – Q2 2024 – Psychedelic Therapeutics & Drug Development Conference
Facet Attends Psychedelic Therapeutics & Drug Development Conference In [...]
gET sOCIAL